Skip to main content

Table 3 Sensitivity analysis including cases occurring until 2005 which were strictly validated via mailing

From: Association between cardiovascular risk-factors and venous thromboembolism in a large longitudinal study of French women

 

All VTE

Pulmonary embolism

DVT

Primary

Secondary

 

Cases

adjusted HR*

Cases

adjusted HR*

Cases

adjusted HR*

Cases

adjusted HR*

Cases

adjusted HR*

physical act T1

413

ref

97

ref

316

ref

154

ref

259

ref

physical activity T2

422

1.04 (0.90: 1.19)

97

1.05 (0.79: 1.39)

325

1.03 (0.88: 1.21)

148

0.97 (0.77: 1.22)

274

1.08 (0.91: 1.28)

physical activity T3

394

0.98 (0.85: 1.12)

96

1.00 (0.75: 1.33)

298

0.97 (0.83: 1.14)

107

0.70 (0.54: 0.90)

287

1.14 (0.96: 1.34)

Never smoker

721

Ref

172

ref

549

ref

241

ref

480

ref

X smoker

383

0.92 (0.82: 1.05)

88

0.93 (0.72: 1.20)

295

0.92 (0.80; 1.07)

120

0.87 (0.71: 1.09)

263

0.95 (0.82: 1.10)

smoker

125

0.89 (0.74: 1.08)

30

0.99 (0.67: 1.47)

95

0.86 (0.69: 1.07)

48

1.05 (0.77: 1.44)

77

0.81 (0.64: 1.04)

hypertension

583

1.02 (0.91: 1.15)

162

1.22 (0.95: 1.56)

421

0.97 (0.84: 1.11)

191

0.96 (0.78: 1.18)

392

1.05 (0.91: 1.22)

dyslipidaemia

189

0.86 (0.73: 1.01)

52

0.87 (0.64: 1.19)

137

0.86 (0.71: 1.04)

58

0.74 (0.56: 0.99)

131

0.93 (0.76: 1.13)

diabetes

21

0.71 (0.46: 1.11)

6

0.68 (0.30: 1.54)

15

0.73 (0.44: 1.22)

10

1.01 (0.54: 1.92)

11

0.56 (0.31: 1.03)

  1. *adjusted on education level, statin use, menopause, MHT use, parity, type of menopause, family history of CVD and BMI